Form 4: Cara Therapeutics Executive Sells Shares to Cover Tax Obligations

Scott Terrillion, a Cara Therapeutics officer, sold 2,753 shares of common stock to cover tax obligations related to vesting restricted stock units.

Summary

• On April 5, 2024, Scott Terrillion, Secretary, Chief Compliance Officer, and General Counsel of Cara Therapeutics, sold 2,753 shares of common stock.
• The sale was executed at a price of $0.83 per share.
• The transaction was conducted to cover tax withholding obligations triggered by the vesting of restricted stock units.
• Following the transaction, Terrillion directly owns 88,247 shares of Cara Therapeutics common stock.
• The sale was executed pursuant to a pre-arranged 'sell to cover' arrangement adopted on September 7, 2018, in accordance with Rule 10b5-1.

Sentiment

Score: 5

Explanation: The document describes a routine transaction (stock sale to cover taxes) and doesn't indicate any significant positive or negative sentiment.

Future Outlook

There is no future outlook provided in this document.

Industry Context

This is a routine Form 4 filing, which is common for corporate insiders who sell shares of their company's stock. The sale was to cover tax obligations, which is a typical reason for such transactions.

Stakeholder Impact

• The sale of shares by an officer could have a minor negative impact on shareholder sentiment, but is unlikely to be significant given the reason for the sale.

Key Dates